MedPath

Mental Imagery and Targeted Memory Reactivation in PTSD

Not Applicable
Recruiting
Conditions
Nightmares, REM-Sleep Type
PTSD
Interventions
Behavioral: Imagery Rehearsal Therapy
Behavioral: Imagery Rehearsal Therapy and Targeted memory reactivation during REM sleep
Registration Number
NCT05933109
Lead Sponsor
University Hospital, Geneva
Brief Summary

With this protocol, investigators examine whether targeted memory reactivation (TMR), a technique used to strengthen memories, can accelerate remission of traumatic nightmares and post-traumatic stress disorder (PTSD) symptomatology. This protocol uses TMR during REM sleep to strengthen positive memories generated by Imagery Rehearsal Therapy (IRT), a recommended treatment of nightmares. Patients with PTSD are asked to perform 3 weekly IRT sessions and, while they generate a positive outcome of their recurrent nightmare, half of the patients are exposed to a sound S1 (TMR group), while the other half is not exposed to this sound (control group). All patients will perform IRT every evening at home and will be exposed to the sound S1 during REM sleep with a wireless headband, which automatically detects sleep stages. Clinical evaluation of the severity of PTSD and nightmares before and after (1-month follow-up and 3-months follow-up) this intervention takes place using the validated Clinically Administered PTSD Scale for DSM-5 (CAPS-5, primary outcome measure). The investigators hypothesize that patients treated with IRT and who are exposed, during REM sleep to a sound that had previously been associated with the new positive dream scenario of IRT (TMR group), will have more reduced frequency of PTSD severity and nightmares compared to participants with stimulation of the same, but non-associated, sound during REM sleep (control group).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • with untreated persistent PTSD according to DSM-5 (> 1 month), suffering from chronic nightmares
  • with no active specific treatment for PTSD
Exclusion Criteria
  • patients with active specific treatment for PTSD
  • patients with neurological disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupImagery Rehearsal TherapyPatients will not receive the sound S1 while they generate a positive outcome of imagery rehearsal therapy (IRT). During REM sleep, they will receive the same sound as the experimental group (S1) under the same conditions.
TMR groupImagery Rehearsal Therapy and Targeted memory reactivation during REM sleepPatients will receive a sound S1 while they generate a positive outcome of imagery rehearsal therapy (IRT). They will also receive the sound S1 during REM sleep.
Primary Outcome Measures
NameTimeMethod
Clinician-Administered PTSD Scale for DSM-53 months

Validated questionnaire that assesses PTSD symptoms, the score ranges from 0-80, zero indicating no symptom severity and 80 indicating the higher symptom severity.

Secondary Outcome Measures
NameTimeMethod
Beck Depression Inventory3 months

Validated self-report scale to assess depressive symptoms, the score ranges from 0-63, zero indicating no symptom severity and 63 indicating the higher symptom severity.

Pittsburgh Sleep Quality Index3 months

Validated self-report scale to assess the quality of sleep, the score ranges from 0-21, zero indicating no symptom severity and 21 indicating the higher symptom severity.

PTSD Checklist for DSM53 months

Validated self-report measure of PTSD, the score ranges from 0-80, zero indicating no symptom severity and 80 indicating the higher symptom severity.

Nightmare Frequency3 months

Number of nightmares per week

Nightmare Distress Questionnaire3 months

Validated self-report scale to assess the emotional disturbance attributed to the nightmares, the score ranges from 0-52, zero indicating no symptom severity and 52 indicating the higher symptom severity.

Positive emotions in dreams3 months

Use of a dream diary

Trial Locations

Locations (1)

Center for Sleep Medicine

🇨🇭

Geneva, Switzerland

© Copyright 2025. All Rights Reserved by MedPath